Department of Obstetrics and Gynaecology, Monash Medical Centre, Monash Health, 246 Clayton Rd, Clayton, VIC, 3168, Australia.
Department of Obstetrics and Gynaecology, Joan Kirner Women's and Children's Hospital, 176 Furlong Rd, St Albans, Australia.
Arch Gynecol Obstet. 2022 Dec;306(6):2027-2033. doi: 10.1007/s00404-022-06736-5. Epub 2022 Aug 22.
Hysterectomy is a common but expensive and morbid procedure. Alternative treatments for heavy menstrual bleeding (HMB) are effective in up to 80% of cases, but there is substantial variation in surgical approach and pre-operative management of HMB. This study aims to assess the approach to hysterectomies for benign indications including alternative treatments and route of operation.
We retrospectively collected patient and surgical data on all hysterectomies for benign indications from 1/4/2018 to 31/6/2020 at our tertiary-led hospital network.
Hysterectomies were performed in 582 women at a median age of 49(44-56) with a median BMI of 27.9(24.5-33.3)kg/m and 251(43%) were referred from private rooms. Hysterectomies for HMB were performed laparoscopically (TLH)(156, 51.7%) more often than abdominally (TAH)(133, 44%) or vaginally (4.3, 13%), with wide variation between sites. Approach was predicted by a history of previous abdomino-pelvic surgery and uterine size but not by other patient factors (BMI, parity or comorbidities). Referral source, on the other hand, was a significant predictor of route of hysterectomy. In women with HMB without uterine abnormalities, 45% tried a levonorgestrel intrauterine device and 25% tried endometrial ablation before proceeding to surgery. The use of alternative therapies pre-operatively did not vary between sites or referral sources.
The variations in route of hysterectomy that are unexplained by patient factors suggest room for improvement and raises the question whether some of the patients undergoing a TAH may have been candidates for less invasive surgery. Uptake of alternative management strategies for HMB could also be improved.
子宫切除术是一种常见但昂贵且病态的手术。对于月经过多(HMB)的替代治疗在多达 80%的病例中是有效的,但在 HMB 的手术方法和术前管理方面存在很大差异。本研究旨在评估用于良性指征的子宫切除术方法,包括替代治疗和手术途径。
我们回顾性地收集了 2018 年 4 月 1 日至 2020 年 6 月 31 日期间我们的三级医院网络中所有因良性指征进行的子宫切除术患者和手术数据。
在中位年龄为 49 岁(44-56 岁)、中位 BMI 为 27.9(24.5-33.3)kg/m 的 582 名女性中进行了子宫切除术,其中 251 名(43%)来自私人病房。HMB 行腹腔镜子宫切除术(TLH)(156 例,51.7%)多于开腹手术(TAH)(133 例,44%)或经阴道手术(4.3%,13%),各部位之间差异较大。手术途径由既往腹部-骨盆手术史和子宫大小预测,但不受其他患者因素(BMI、产次或合并症)影响。另一方面,转诊来源是子宫切除术途径的显著预测因素。对于无子宫异常的 HMB 妇女,45%的人在手术前尝试了左炔诺孕酮宫内节育器,25%的人尝试了子宫内膜消融。术前替代治疗的使用在不同部位或转诊来源之间没有差异。
无法用患者因素解释的子宫切除术途径的差异表明仍有改进的空间,并提出了一些接受 TAH 的患者是否可能成为微创手术候选者的问题。HMB 替代管理策略的采用也可以得到改善。